Re: Breakout
|
|
Mannkind
|
Mar 11, 2013 05:43PM
|
Re: Divine Skin Appoints Two New Independent Directors
|
|
Mannkind
|
Nov 28, 2012 04:40PM
|
Re: new member
|
|
Mannkind
|
Mar 29, 2012 10:19PM
|
Re: Monster Pre-market Trade
|
|
Mannkind
|
Feb 19, 2013 11:26AM
|
Re: Linking HF to clinical trials
|
|
Mannkind
|
May 02, 2013 08:55AM
|
Re: 2015 Leaps
|
|
Mannkind
|
Sep 18, 2012 02:58PM
|
Re: Just a reminder
|
|
Mannkind
|
Jun 19, 2012 03:27PM
|
Likelihood of a multibillion $ drug
|
|
Mannkind
|
Sep 21, 2012 10:29AM
|
Re: Michael Higgins on Biotech Names with Major Market Potential
|
|
Mannkind
|
Dec 21, 2012 09:31AM
|
Re: Does Dreamboat Qualify?
|
|
Mannkind
|
Dec 11, 2012 09:09AM
|
Advantages/ Disadvantages To Having No Partner For Afrezza
|
|
Mannkind
|
Oct 30, 2012 10:42AM
|
Re: Just a reminder
|
|
Mannkind
|
Jun 19, 2012 03:39PM
|
Re: Annual shareholders meeting
|
|
Mannkind
|
May 21, 2013 08:33AM
|
Re: 6 Biotechnology Stocks to Sell Now
|
|
Mannkind
|
Sep 27, 2012 11:46AM
|
New 8-K Opens Up Credit Line
|
|
Mannkind
|
Dec 26, 2012 09:21AM
|
Re: Advantages/ Disadvantages To Having No Partner For Afrezza
|
|
Mannkind
|
Oct 31, 2012 09:35AM
|
Re: More Suit Filings
|
|
Mannkind
|
Sep 19, 2012 09:07AM
|
Re: New SA Article
|
|
Mannkind
|
Jun 27, 2013 09:58AM
|
Re: The return of Lily Munster
|
|
Mannkind
|
Aug 06, 2013 09:14AM
|
Re: Faruqi & Faruqi, LLP Launches An Investigation Against Mannkind Corp. (MNKD) For
|
|
Mannkind
|
Nov 20, 2012 09:53AM
|